DexCom Inc

DXCM · Moat type: UNBESTIMMT

MoatScore

8/10

Fair Value

92 USD

Margin of Safety

+22.2 %

Rating

BEOBACHTEN

DexCom develops, manufactures, and distributes continuous glucose monitoring systems (CGM) for diabetes patients, operating a hybrid business model through the sale of sensors (consumables) and receiver devices, combining one-time hardware sales with recurring sensor subscriptions.

View full analysis →

🔒 Detailed AI analysis, peer comparison, capital allocation, crisis resilience & PDF report for Pro members.

Not investment advice. Analyses are research, not a recommendation. Valuations may be erroneous or incomplete. © MoatScan.ai — proprietary methodology.